Clinical Trials Directory

Trials / Completed

CompletedNCT02029040

Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis

A Randomized Trial of Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in The Emergency Department

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
2 Months – 12 Months
Healthy volunteers
Not accepted

Summary

This is a randomized, double-blind, controlled trial in the Pediatric Emergency Department. The primary objective is to determine whether nebulized 3% hypertonic saline is more effective than nebulized 0.9% saline in the treatment of bronchiolitis in the emergency department.

Conditions

Interventions

TypeNameDescription
DRUG3% Hypertonic SalineWithin 5-15 minutes following the administration of the study drug, the Respiratory Distress Assessment Instrument (RDAI) score will be reassessed and study interventions are complete. The patient will be observed for one hour in the emergency department (ED). However, further treatments may be started immediately upon discretion of the treating physician. If the patient is discharged home study PI and/or research assistant will call the parents 7 days from the ED visit to check the number of visits to their primary doctor and/or EDs due to same illness.
DRUG0.9 % normal salineWithin 5-15 minutes following the administration of the study drug, the Respiratory Distress Assessment Instrument (RDAI) score will be reassessed and study interventions are complete. The patient will be observed for one hour in the emergency department (ED). However, further treatments may be started immediately upon discretion of the treating physician. If the patient is discharged home study PI and/or research assistant will call the parents 7 days from the ED visit to check the number of visits to their primary doctor and/or EDs due to same illness.

Timeline

Start date
2013-12-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2014-01-07
Last updated
2019-01-25
Results posted
2019-01-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02029040. Inclusion in this directory is not an endorsement.